Of 18 CSA cases, 7 were already confirmed to be XLSA due to mutation of ALAS2 before registration in this study, and the others were diagnosed as CSA based on family history or clinical findings, including responsiveness to Vit.B6 treatment. Here, ALAS2 is linked to chromosome-type aberration frequency.